Literature DB >> 36018488

Machine learning-based radiomics for multiple primary prostate cancer biological characteristics prediction with 18F-PSMA-1007 PET: comparison among different volume segmentation thresholds.

Kun Tang1, Yunjun Yang2, Fei Yao3, Shuying Bian3, Dongqin Zhu4, Yaping Yuan5, Kehua Pan3, Zhifang Pan5, Xianghao Feng6.   

Abstract

BACKGROUND: PET-based radiomics features could predict the biological characteristics of primary prostate cancer (PCa). However, the optimal thresholds to predict the biological characteristics of PCa are unknown. This study aimed to compare the predictive power of 18F-PSMA-1007 PET radiomics features at different thresholds for predicting multiple biological characteristics.
METHODS: One hundred and seventy-three PCa patients with complete preoperative 18F-PSMA-1007 PET examination and clinical data before surgery were collected. The prostate lesions' volumes of interest were semi-automatically sketched with thresholds of 30%, 40%, 50%, and 60% maximum standardized uptake value (SUVmax). The radiomics features were respectively extracted. The prediction models of Gleason score (GS), extracapsular extension (ECE), and vascular invasion (VI) were established using the support vector machine. The performance of models from different thresholding regions was assessed using receiver operating characteristic curve and confusion matrix-derived indexes.
RESULTS: For predicting GS, the 50% SUVmax model showed the best predictive performance in training (AUC, 0.82 [95%CI 0.74-0.88]) and testing cohorts (AUC, 0.80 [95%CI 0.66-0.90]). For predicting ECE, the 40% SUVmax model exhibit the best predictive performance (AUC, 0.77 [95%CI 0.68-0.84] and 0.77 [95%CI 0.63-0.88]). As for VI, the 50% SUVmax model had the best predictive performance (AUC, 0.74 [95%CI 0.65-0.82] and 0.74 [95%CI 0.56-0.82]).
CONCLUSION: The 18F-1007-PSMA PET-based radiomics features at 40-50% SUVmax showed the best predictive performance for multiple PCa biological characteristics evaluation. Compared to the single PSA model, radiomics features may provide additional benefits in predicting the biological characteristics of PCa.
© 2022. Italian Society of Medical Radiology.

Entities:  

Keywords:  Machine learning; PET; PSMA-1007; Prostate cancer; Radiomics

Mesh:

Substances:

Year:  2022        PMID: 36018488     DOI: 10.1007/s11547-022-01541-1

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   6.313


  39 in total

1.  Blood vascular invasion: a poor prognostic factor in adenocarcinoma of the prostate.

Authors:  A M Kwart; J E Sims
Journal:  J Urol       Date:  1978-01       Impact factor: 7.450

2.  68Ga-PSMA-PET/CT imaging of localized primary prostate cancer patients for intensity modulated radiation therapy treatment planning with integrated boost.

Authors:  Lena Thomas; Steffi Kantz; Arthur Hung; Debra Monaco; Florian C Gaertner; Markus Essler; Holger Strunk; Wolfram Laub; Ralph A Bundschuh
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-02-21       Impact factor: 9.236

3.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

4.  The relationship between the extent of extraprostatic extension and survival following radical prostatectomy.

Authors:  Byong Chang Jeong; Heather J Chalfin; Seung Bae Lee; Zhaoyong Feng; Jonathan I Epstein; Bruce J Trock; Alan W Partin; Elizabeth Humphreys; Patrick C Walsh; Misop Han
Journal:  Eur Urol       Date:  2014-06-23       Impact factor: 20.096

5.  Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer.

Authors:  Ayman S Moussa; Jianbo Li; Meghan Soriano; Eric A Klein; Fei Dong; J Stephen Jones
Journal:  BJU Int       Date:  2008-09-08       Impact factor: 5.588

6.  Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

Authors:  A V D'Amico; R Whittington; S B Malkowicz; D Schultz; K Blank; G A Broderick; J E Tomaszewski; A A Renshaw; I Kaplan; C J Beard; A Wein
Journal:  JAMA       Date:  1998-09-16       Impact factor: 56.272

Review 7.  Fluorine-18 labelled prostate-specific membrane antigen (PSMA)-1007 positron-emission tomography-computed tomography: normal patterns, pearls, and pitfalls.

Authors:  R W Foley; S L Redman; R N Graham; W W Loughborough; D Little
Journal:  Clin Radiol       Date:  2020-08-08       Impact factor: 2.350

Review 8.  Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a review.

Authors:  A Marije Hoogland; Charlotte F Kweldam; Geert J L H van Leenders
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

Review 9.  Keeping up with the prostate-specific membrane antigens (PSMAs): an introduction to a new class of positron emission tomography (PET) imaging agents.

Authors:  Marcin Czarniecki; Esther Mena; Liza Lindenberg; Marek Cacko; Stephanie Harmon; Jan Philipp Radtke; Frederick Giesel; Baris Turkbey; Peter L Choyke
Journal:  Transl Androl Urol       Date:  2018-10

10.  Decision-support for treatment with 177Lu-PSMA: machine learning predicts response with high accuracy based on PSMA-PET/CT and clinical parameters.

Authors:  Sobhan Moazemi; Annette Erle; Zain Khurshid; Susanne Lütje; Michael Muders; Markus Essler; Thomas Schultz; Ralph A Bundschuh
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.